Roivant Sciences Ltd. Insider Trades

Insider Trading History

Track insider trading activity for Roivant Sciences Ltd.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Immunovant
Immunovant IMVT
10% owner
Holding Value $3.53B 113,317,007 shares
Last Trade
Dec 12, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$441M 16,666,666 shares
$26.44
$31.15
Immunovant
Immunovant IMVT
10% owner
Holding Value $3.01B 96,650,341 shares
Last Trade
Jan 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$383M 16,845,010 shares
$22.75
$31.15
Immunovant
Immunovant IMVT
10% owner
Holding Value $2.49B 79,805,331 shares
Last Trade
Oct 02, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58M 1,526,316 shares
$38.00
$31.15
Immunovant
Immunovant IMVT
10% owner
Holding Value $2.44B 78,279,015 shares
Last Trade
Oct 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170M 4,473,684 shares
$38.00
$31.15
Roivant Sciences
Roivant Sciences ROIV
10% owner
Holding Value $2.25B 78,279,015 shares
Last Trade
Oct 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47M 4,473,684 shares
$10.52
$28.70
Roivant Sciences
Roivant Sciences ROIV
10% owner
Holding Value $2.29B 79,805,331 shares
Last Trade
Oct 02, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$16M 1,526,316 shares
$10.52
$28.70
Immunovant
Immunovant IMVT
Director
Holding Value $2.3B 73,805,331 shares
Last Trade
Oct 06, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.09M 416,667 shares
$9.82
$31.15
Arbutus Biopharma
Arbutus Biopharma ABUS
10% owner
Holding Value $169M 38,847,462 shares
Last Trade
Oct 18, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$94.5M 22,833,922 shares
$4.14
$4.35
Arbutus Biopharma
Arbutus Biopharma ABUS
10% owner
Holding Value $0 0 shares
Last Trade
Oct 18, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$4.82M 1,164,000 shares
$4.14
$4.35
Immunovant
Immunovant IMVT
10% owner
Holding Value $2.29B 73,388,664 shares
Last Trade
Aug 02, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$132M 17,021,276 shares
$7.74
$31.15
Immunovant
Immunovant IMVT
10% owner
Holding Value $1.76B 56,367,388 shares
Last Trade
Sep 17, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$337M 8,773,969 shares
$38.43
$31.15
Immunovant
Immunovant IMVT
10% owner
Holding Value $1.48B 47,593,419 shares
Last Trade
Sep 04, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.5M 380,000 shares
$33.00
$31.15
Immunovant
Immunovant IMVT
10% owner
Holding Value $1.47B 47,213,419 shares
Last Trade
May 12, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$199M 8,773,969 shares
$22.70
$31.15
Immunovant
Immunovant IMVT
10% owner
Holding Value $1.2B 38,439,450 shares
Last Trade
Apr 16, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.5M 1,034,483 shares
$18.89
$31.15
Sio Gene Therapies
Sio Gene Therapies SIOX
10% owner
Holding Value $8.88M 18,577,380 shares
Last Trade
Feb 24, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20M 5,333,333 shares
$3.75
$0.48
Myovant Sciences
Myovant Sciences MYOV
10% owner
Holding Value $0 0 shares
Last Trade
Dec 27, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$712M 45,008,604 shares
$15.81
$26.98
Immunovant
Immunovant IMVT
10% owner
Holding Value $1.17B 37,404,967 shares
Last Trade
Dec 18, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$513M 36,929,967 shares
$13.88
$31.15
Myovant Sciences
Myovant Sciences MYOV
10% owner
Holding Value $1.21B 45,008,604 shares
Last Trade
Dec 17, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.2M 75,000 shares
$15.94
$26.98
Myovant Sciences
Myovant Sciences MYOV
10% owner
Holding Value $1.21B 44,933,604 shares
Last Trade
Dec 16, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.57M 170,000 shares
$15.13
$26.98
Myovant Sciences
Myovant Sciences MYOV
10% owner
Holding Value $1.21B 44,763,604 shares
Last Trade
Dec 04, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.28M 75,000 shares
$17.06
$26.98

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up